Henan Lingrui Pharmaceutical Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 1,749.409 million compared to CNY 1,691.027 million a year ago. Operating income was CNY 314.759 million compared to CNY 309.653 million a year ago. Net income was CNY 269.569 million compared to CNY 261.818 million a year ago. Basic earnings per share from continuing operations was CNY 0.475 compared to CNY 0.449 a year ago.